Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally https://francesbzxg981775.topbloghub.com/45483421/semaglutide-a-potential-solution-for-metabolic-disorders